Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Consolidated Net Income (2023 - 2025)

Historic Consolidated Net Income for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$55.8 million.

  • Nuvation Bio's Consolidated Net Income fell 3538.46% to -$55.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$217.5 million, marking a year-over-year increase of 5914.19%. This contributed to the annual value of -$567.9 million for FY2024, which is 64924.01% down from last year.
  • According to the latest figures from Q3 2025, Nuvation Bio's Consolidated Net Income is -$55.8 million, which was down 3538.46% from -$59.0 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Consolidated Net Income peaked at -$13.8 million during Q4 2023, and registered a low of -$462.5 million during Q2 2024.
  • In the last 3 years, Nuvation Bio's Consolidated Net Income had a median value of -$41.2 million in 2024 and averaged -$73.8 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first crashed by 214075.58% in 2024, then soared by 8724.15% in 2025.
  • Nuvation Bio's Consolidated Net Income (Quarter) stood at -$13.8 million in 2023, then tumbled by 258.63% to -$49.4 million in 2024, then decreased by 12.84% to -$55.8 million in 2025.
  • Its last three reported values are -$55.8 million in Q3 2025, -$59.0 million for Q2 2025, and -$53.2 million during Q1 2025.